Table 1. Demographic and clinical data of the study participants in selected drug-resistant TB Treatment Centers, Ethiopia, May 2020 (n = 204).
| Variable | Frequency | Proportion | |
|---|---|---|---|
| Gender | |||
| Male | 140 | 68.6% | |
| Female | 64 | 31.4% | |
| Age | |||
| 15–24 | 61 | 29.9% | |
| 25–34 | 83 | 40.7% | |
| 35–44 | 33 | 16.2% | |
| 45–54 | 14 | 6.8% | |
| ≥ 55 | 13 | 6.4% | |
| Residence | |||
| Rural | 31 | 15.2% | |
| Urban | 173 | 84.8% | |
| Treatment History | |||
| New | 88 | 43.1% | |
| First-line | 96 | 47.1% | |
| Second line | 20 | 9.8% | |
| TB Classification | |||
| New | 88 | 43.1% | |
| Relapse | 66 | 32.4% | |
| Failure | 44 | 21.6% | |
| Defaulter | 6 | 2.9% | |
| HIV Status | |||
| Negative | 173 | 84.8% | |
| Positive | 31 | 15.2% | |
| Smear Results | |||
| Negative | 100 | 49.0% | |
| Positive (Scanty) | 23 | 11.3% | |
| Positive (+1) | 37 | 18.1% | |
| Positive (+2) | 21 | 10.3% | |
| Positive (+3) | 23 | 11.3% | |
| Living of Participant | Addis Ababa | 86 | 42.2% |
| Amhara | 13 | 6.4% | |
| BenishangulGumz | 5 | 2.4% | |
| Gambella | 12 | 5.9% | |
| Oromia | 35 | 17.1% | |
| SNNP | 53 | 26.0% |